PKI Share Price

Open 54.78 Change Price %
High 55.13 1 Day -0.07 -0.13
Low 54.66 1 Week -0.90 -1.61
Close 55.04 1 Month 2.72 5.20
Volume 971929 1 Year 7.09 14.79
52 Week High 57.28
52 Week Low 45.35
PKI Important Levels
Resistance 2 55.48
Resistance 1 55.30
Pivot 54.94
Support 1 54.78
Support 2 54.60
NYSE USA Most Active Stocks
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
BAC 24.23 -1.42%
BAC 24.23 -1.42%
BAC 24.23 -1.42%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
BBW 10.10 21.69%
FIX 38.65 17.66%
FIX 38.65 17.66%
FNP 35.24 12.02%
FNP 35.24 12.02%
DMD 6.35 9.48%
DMD 6.35 9.48%
FL 75.01 9.38%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

PerkinElmer, Inc. (NYSE: PKI)

PKI Technical Analysis 3
As on 24th Feb 2017 PKI Share Price closed @ 55.04 and we RECOMMEND Buy for LONG-TERM with Stoploss of 53.07 & Buy for SHORT-TERM with Stoploss of 53.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
PKI Target for February
1st Target up-side 54.83
2nd Target up-side 55.97
3rd Target up-side 57.12
1st Target down-side 51.56
2nd Target down-side 50.41
3rd Target down-side 49.26
PKI Other Details
Segment EQ
Market Capital 3584113920.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.perkinelmer.com
PKI Address
PKI
940 Winter Street
Waltham, MA 02451
United States
Phone: 781-663-6900
PKI Latest News
Interactive Technical Analysis Chart PerkinElmer, Inc. ( PKI NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on PerkinElmer, Inc.
PKI Business Profile
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerates the discovery and development of critical new therapies. This segment provides early detection for genetic disorders from pre-conception to early childhood, as well as offers digital x-ray flat panel detectors and infectious disease testing for the diagnostics market; and a suite of solutions, such as reagents, liquid handling, and detection and imaging technologies that enable researchers to improve the drug discovery process. Its research portfolio includes instrumentation for automation and detection solutions, in vitro and in vivo imaging and analysis hardware and software, and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides services and solutions to facilitate the creation of safer food and consumer products, secure surroundings, and efficient energy resources. This segment offers analytical technologies, solutions, and services that enable its customers to understand the health aspects of environment, including air, water, soil, and food; analytical instrumentation for the industrial market that comprise the chemical, petrochemical, lubricant, electronics, semiconductor, and quality assurance industries; and laboratory services. The company markets its products and services under various brands directly through its own sales force. Its customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.